| DWS INVEST GOLD AND PRECIOUS METALS EQUITIES FC | RVI MATERIAS PRIMAS | 57,72% | 186,69% | 161,18% | 240,60% |
| MAN JAPAN COREALPHA EQUITY D H USD | RVI JAPÓN | 57,67% | 109,31% | · | 435,31% |
| DWS INVEST GOLD AND PRECIOUS METALS EQUITIES TFC | RVI MATERIAS PRIMAS | 57,66% | 186,44% | 160,97% | · |
| JPM JAPAN STRATEGIC VALUE C (ACC) EUR (HEDGED) | RVI JAPÓN VALOR | 57,66% | 141,01% | 210,84% | · |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | RVI BIOTECNOLOGÍA | 57,66% | 21,60% | -24,16% | · |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 57,66% | 22,28% | -23,07% | · |
| T.ROWE EMERGING MARKETS EQUITY FUND A | RVI EMERGENTES | 57,65% | 48,91% | 11,28% | 82,48% |
| T.ROWE EMERGING MARKETS EQUITY FUND A (EUR) | RVI EMERGENTES | 57,65% | 48,86% | 11,12% | 82,22% |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES A2 USD (HEDGED) | RVI JAPÓN SMALL/MID CAP | 57,63% | 116,82% | 140,90% | 301,90% |
| ALLIANZ GLOBAL METALS AND MINING AT EUR | RVI MATERIAS PRIMAS | 57,62% | 58,87% | 72,85% | 197,07% |
